23-04-2025
Cheaper Chinese HPV Vaccines Turn Merck's Gardasil From Boom to Bust
By , Karoline Kan, and Amber Tong
Save
Merck & Co. Chief Executive Officer Robert Davis was tired of talking about China.
On an earnings call in February, he answered question after question about plunging demand for his company's vaccine against cancer-causing HPV in China, which previously powered Merck's growth.
